Trident Texofab Ltd - Stock Valuation and Financial Performance

BSE: 540726 | NSE: | Textile | Small Cap

Trident Texofab Share Price

161.90 3.15 1.98%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Trident Texofab

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Trident Texofab stock performance -

mw4me loader
P/E Ratio (SA):
75.65
Market Cap:
163 Cr.
52-wk low:
36.2
52-wk high:
161.9

Is Trident Texofab Ltd an attractive stock to invest in?

1. Is Trident Texofab Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Trident Texofab Ltd is a below average quality company.

2. Is Trident Texofab Ltd undervalued or overvalued?

The key valuation ratios of Trident Texofab Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Trident Texofab Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Trident Texofab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Trident Texofab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Trident Texofab Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 11.9%9.9%15.9%16.1%13.1%14.3%9.8%9%13.1%10.1%-
Value Creation
Index
-0.2-0.30.10.2-0.10.0-0.3-0.4-0.1-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 62.6667685.586.99149.984.396.499.5105
Sales YoY Gr.-5.5%15.1%12.5%1.7%4.7%-45.1%68.9%14.3%3.2%-
Adj EPS 2.52.640.61.210.30.92.30.92.1
YoY Gr.-1.2%57%-84.1%90.6%-21.3%-69.8%220.7%146.2%-62.9%-
BVPS (₹) 43.143.547.68.61111.811.912.815.116.117.8
Adj Net
Profit
0.20.20.30.61.20.90.30.92.30.92
Cash Flow from Ops. 00.70.1-2.5-2.8-2.921.45.92.7-
Debt/CF from Ops. -128.84.341.1-2.1-5.4-7.815.925.65.913.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.3%2.7%25.9%3.2%
Adj EPS -11.4%-7%43.1%-62.9%
BVPS-10.4%8%10.8%7.2%
Share Price - 34.1% 52.1% 155.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
6.95.98.810.212.28.22.57.516.45.512.6
Op. Profit
Mgn %
1.91.51.51.72.85.35.85.76.66.24
Net Profit
Mgn %
0.30.30.40.71.410.61.12.40.92.1
Debt to
Equity
1.20.91.40.61.41.92.62.82.32.31
Working Cap
Days
14717313612615214730418517619489
Cash Conv.
Cycle
27223182961136989810520

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 12.60%

Sales growth is growing at healthy rate in last 3 years 25.85%

Net Profit is growing at healthy rate in last 3 years 43.11%

Sales growth is good in last 4 quarters at 10.88%

Debt to equity has increased versus last 3 years average to 2.28

Latest Financials - Trident Texofab Ltd.

Standalone Consolidated
TTM EPS (₹) 2.1 -
TTM Sales (₹ Cr.) 105 -
BVPS (₹.) 17.8 -
Reserves (₹ Cr.) 8 -
P/BV 9.08 -
PE 75.65 -
From the Market
52 Week Low / High (₹) 36.15 / 161.90
All Time Low / High (₹) 13.33 / 206.00
Market Cap (₹ Cr.) 163
Equity (₹ Cr.) 10.1
Face Value (₹) 10
Industry PE 30.2

Management X-Ray of Trident Texofab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Trident Texofab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales63667685879150849699
Operating Expenses 61657584848647809093
Manufacturing Costs0000121233
Material Costs59637282807942728084
Employee Cost 1111222222
Other Costs 1111332444
Operating Profit 1111253566
Operating Profit Margin (%) 1.9%1.5%1.5%1.7%2.8%5.3%5.8%5.7%6.5%6.2%
Other Income 0000002120
Interest 1111133344
Depreciation 0000011122
Exceptional Items 0000000000
Profit Before Tax 0011221131
Tax 0000011010
Profit After Tax 0001110121
PAT Margin (%) 0.3%0.1%0.4%0.9%1.5%1.0%0.7%1.2%2.3%1.1%
Adjusted EPS (₹)0.30.10.50.81.30.90.41.02.21.1
Dividend Payout Ratio (%)0%0%0%53%31%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 3348111212131516
Share Capital 00044410101010
Reserves 3334772356
Minority Interest0000000000
Debt4354132029333234
Long Term Debt115491119201918
Short Term Debt220041010131316
Trade Payables21311530191616111817
Others Liabilities 11124810131315
Total Liabilities 28382445475668717782

Fixed Assets

Gross Block222231417252928
Accumulated Depreciation0001123457
Net Fixed Assets211221214222322
CWIP 0000609400
Investments 0013112244
Inventories7925410871114
Trade Receivables19261532292630313437
Cash Equivalents 0020000000
Others Assets1133354566
Total Assets 28382445475668717782

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 010-2-3-32163
PBT 0011221131
Adjustment 0000143546
Changes in Working Capital -01-0-3-5-8-2-5-1-4
Tax Paid 0000-1-10000
Cash Flow From Investing Activity 10-1-2-7-2-10-40-1
Capex 1000-8-2-10-400
Net Investments 000-21-10-100
Others 0000000010
Cash Flow From Financing Activity -1-12310583-6-2
Net Proceeds from Shares 1004200000
Net Proceeds from Borrowing -2-15-15291-3-1
Interest Paid 0000-1-2-3-2-3-4
Dividend Paid 0000000000
Others 00-20362403
Net Cash Flow 002-2000000
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)6.171.79.0712.4413.568.253.047.9115.86.88
ROCE (%)11.919.8715.916.113.1214.289.88.9513.0710.11
Asset Turnover Ratio2.271.992.432.5521.870.821.221.311.26
PAT to CFO Conversion(x)N/AN/AN/A-2-3-3N/A133
Working Capital Days
Receivable Days10612410098122106206132122128
Inventory Days34442815182766333444
Payable Days11414911510111482140706675

Trident Texofab Ltd Stock News

Trident Texofab Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Trident Texofab on 20-Dec-2024 16:59 is ₹161.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Trident Texofab stood at ₹163.0.
The latest P/E ratio of Trident Texofab as of 20-Dec-2024 16:59 is 75.65.
The latest P/B ratio of Trident Texofab as of 20-Dec-2024 16:59 is 9.08.
The 52-week high of Trident Texofab is ₹161.9 and the 52-week low is ₹36.15.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Trident Texofab is ₹105.3 ( Cr.) .

About Trident Texofab Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.